Pharma

graphic image of China flags overlapping with US flags

Biotech

Instil's licensed PD-L1xVEGF bispecific shows promise in China

Tumors diminished in 62% of patients with advanced non-small cell lung cancer given IMM2510, instilling hope for an upcoming U.S. trial.

Darren Incorvaia Jul 31, 2025 2:10pm

Fierce Pharma

AbbVie will continue to pursue external innovation for long-term

Jul 31, 2025 11:44am

Boerner

Fierce Pharma

BMS touts commercial execution, reckons with clinical setbacks

Jul 31, 2025 11:10am

Stop sign

Nuvectis axes ovarian cancer program after seeing phase 1b data

Jul 31, 2025 9:15am

Graphic of a fork in the road with arrows pointing in either direction

Fierce Pharma

Prasad exit signals more permissive FDA for cell and gene field

Jul 31, 2025 9:10am

Question

AbbVie in talks over $1B Gilgamesh buyout: report

Jul 31, 2025 7:48am